Point72 Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Buy
24,800
+8,000
+48% +$557K ﹤0.01% 2472
2025
Q4
$1.12M Buy
16,800
+11,700
+229% +$756K ﹤0.01% 2813
2025
Q3
$343K Sell
5,100
-94,900
-95% -$7.51M ﹤0.01% 2033
2025
Q2
$8.73M Hold
100,000
0.02% 786
2025
Q1
$6.83M Buy
+100,000
New +$8.16M 0.02% 819
2023
Q3
Sell
-26,200
Closed -$3.37M 2557
2023
Q2
$3.37M Buy
+26,200
New +$3.17M 0.01% 936

Other funds holding DXCM

Point72 Asset Management's DXCM Position: Q1 2026 in Review

Point72 Asset Management reduced its DexCom (DXCM) stake by 79% in Q1 2026, selling an estimated $66.9M and leaving 257,298 shares worth $16.2M. The position accounts for 0.02% of the portfolio, ranked #928.

Point72 Asset Management first reported a position in DXCM in Q4 2015 and has held it in 33 quarters since. The position peaked at $181M in Q1 2023. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Point72 Asset Management held 257,298 shares of DexCom worth $16.2M as of Q1 2026.
  • Point72 Asset Management sold 960,309 DexCom shares in Q1 2026, an estimated $66.9M.
  • DexCom made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #928 holding.
  • Point72 Asset Management first reported a position in DexCom in Q4 2015 and has held it in 33 quarters since.
  • Point72 Asset Management's DexCom position peaked at $181M in Q1 2023.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.